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Abstract: Lymphnode tuberculosis is a disease of great antiquity. It is the commonest form of extra-pulmonary
tuberculosis, and is probably the commonest cause of chronic lymphadenitis in children. Even after the advent of
effective chemotherapy for tuberculosis, it still poses considerable problems in diagnosis and management. The
disease usually presents as a painless lymphadenopathy of the superficial lymphnodes of insidious onset, which
may proceed to abscess and sinus formation if neglected. Cervical nodes are most commonly affected, but multiple
node involvement is common. Differential diagnosis include other infections, neoplasia, congenital conditions in the
head and neck and rarely, drug reactions. Diagnosis, whenever feasible, should be made on the basis of histological
evidence after lymphnode biopsy. Diagnosis, made on clinical grounds has poor specificity and will result in a great
degree of over diagnosis. Recently, the role of fine needle aspiration cytology as an initial screening procedure has
been recognized. The Tuberculosis Research Centre carried out the first clinical trial which established the efficacy
of short course chemotherapy in the treatment of childhood lymphnode tuberculosis. In 168 children with biopsy
confirmed lymphnode tuberculosis treated with an intermittent six month regimen, the cure rate after five years was
95%. The Revised National Tuberculosis Control Programme recommends that patients with lymphnode tuberculosis
(Category 3) should be treated with rifampicin and isoniazid three times a week for six months, with pyrazinamide for
the first two months.
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Tuberculosis of the superficial lymphnodes is the
commonestextra-pulmonarymanifestationofthedisease.
In India, approximately 10-15% of all tuberculosis cases
are extra-pulmonary, and of these 2/3rd are due to
lymphnode disease1. Known as scrofula, the disease
figures prominently in the writings of Hippocrates (460-
377BC)andHerodotus (484?-425?BC).During theMiddle
Ages itwaswidelyprevalent throughoutEurope,andwas
knownas theKingsEvil, andwasbelieved tobe curedby
theRoyal!Touch2.However,itwasnotuntilthe19thcentury,
with the emergence of pathology as a science, that the
tuberculous etiology of scrofula was recognized.
The advent of the HIV pandemic has had an
adverse impact on the global epidemology of
tuberculosis. It has been one of the major causes for the
resurgence of tuberculosis in the developed nations and
has aggravated the already grim tuberculosis situation in
manycountriesinAfricaandAsis3.Thisassociationseems
to be particularly well marked for extra-pulmonary
tuberculosis, especially lymphadenitis which makes the
diagnosis and management of this disorder more
complicated. Studies in Africa have suggested that HIV
positivity of tuberculous lymphadenitis patients
decreased the possibility of histology and culture, both
being indicativeof tuberculosis4.Co-infectionwithHIV
influences several clinical and laboratory features in
patients with tuberculous lymphadenitis5.
CLINICAL FEATURES
Historically, scrofula has been a common disease in
children.However, inwestern countries, in the recentpast,
numerous studies have shown a peak age range of 20-40
years. This shift in age probably reflects the falling
incidence of childhood tuberculosis in the developed
countries6. In India the disease is still common in children
and in young adults7,8,9,10. In a large clinical trial on
lymphnode tuberculosis conducted by the Tuberculosis
Research Centre (TRC) in Madurai, South India
(manuscript in preparation), 35% of patients were aged 12
years or less and87%were aged30years or below. More
than 50% of patients were in the 13-30 years age group.
Whilepulmonary tuberculosis ismore common in
males, tuberculous lymphadenitis in adults shows a
striking female preponderance6,9,10,11. In the TRC clinical
trial in Madurai, there was a strong female to male excess
in the 13-30 year age group. However, in children, this
female preponderance is not seen 9,10. There was a slight
excess of males in the Madurai study, and in an earlier
clinical trial conducted by the TRC on childhood
lymphnode tuberculosis in Chennai, there were equal
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number of males and females12. The reasons for this
discrepancy are not clear. Perhaps hormonal changes
associated with puberty and child bearing have a role to
play.
Tuberculous lymphadenitis usually presents as a
slowly progressive painless enlargement of the
lymphnodes of the neck and sometimes of the axilla or
groin.Untreated, thediseasemayprogress toabscessand
sinus formation. The physical appearance of superficial
tuberculous lymphadenitis has been classified into five
stages by Jones and Campbell13. Stage 1-enlarged, firm,
mobile,discretenodes; Stage2-large, rubberynodes fixed
to surrounding tissues owing to periadenitis; Stage 3-
central softening due to abscess formation; Stage 4-collar
stud abscess formation; and Stage5-sinus tract formation.
Thecervical lymphnodesarethemostcommonly
affected group in tuberculosis. In order of decreasing
frequency, the anterior and posterior cervical, the
supravlavicular and the submandibular nodes are
involved. This was true in both the TRC clinical trials in
Chennai andMadurai.More than 80% of the children had
cervical node involvement.Noteworthywas the frequency
with which multiple groups of nodes were affected. In
the Chennai study, 32%of the children had four groups
of nodes affected and 10% had five or six groups affected.
Isolated axillary node involvement was seen in 6% and
isolated inguinal node involvement in 8% of patients.
Atypical node involvement were also seen: femoral,
pectoral, epitrochlear.
DIAGNOSIS
Thediagnosisof tuberculous lymphadenitishasalways
posed a challenge to the clinician.
The differential diagnosis of this condition are many:
1. Neoplasia  Hodgkins and Non-Hodgkins
lymphoma, sarcoma.
2. Other infectionsacute bacterial infections, viral
infections (infectious mononucleosis), chlamydia,
toxoplasmosis, fungal infections, non-tuberculous
mycobacterial infections, BCG adenitis.
3. Drug reactions  e.g. hydantoin.
4. Sarcoidosis.
5. Non lymphnode swellings  submandibular or
parotid glands, branchial cyst, cystic hygroma,
carotid body tumor, thyroid swellings.
The diagnosis is oftenmade on clinical grounds.
Biopsy of the node is not always done. This may be due
to the fact that either facilities are not available, especially
in rural areas, or reluctance on the part of the patients to
undergothebiopsy.Theimportanceoflymphnodebiopsy
in the diagnosis of this disorder is well illustrated in the
TRC clinical trials. In the Chennai study, laboratory
confirmation of the diagnosis was obtained in less than
50% of the children in whom the pediatrician made a
clinical diagnosis of tuberculous lymphadenitis. Of 373
biopsies done on children in Madurai, histological
evidence to support the clinical diagnosis was available
in only 126(34%). Thus it is clear that the specificity of
clinical diagnosis is low, and a biopsy must be done
whenever feasible. Serial sections should be examined. If
diagnosisismadeonlyonclinicalgroundsalargenumber
of patients would receive unnecessary treatment. This is
not a new finding and has been highlighted by Pamra
and Mathur in their classic study on tuberculous
lymphadenitis in 1974. Of the 44 children <10 years of
age out of a total of 285 cases of cervical lymphadenitis
from eight centers, only 25 (57%) were confirmed as
tuberculosis, 18 (41%) as non-specific lymphadenitis and
1 (2%) as malignancy9. Fourteen years later the scenario
was no different, with only 23 of 62 (37%) children with
cervical lymphadenitis being confirmed as tuberculosis10.
Four distinct types of histological features were
seen in lymphnode biopsies in children at TRC14. Most
commonwas the reactivetypewith typical tuberculous
granuloma, with fine eosinophilic caseation necrosis,
epithelioidcells,gaintcells,plasmacellsandlymphocytes,
constituting 54% of all cases. Next in frequency was the
hyperplastic type with well differentiated epithelioid cell
granuloma with very little necrosis (29%). The remaining
werehyporeactive type-a poorly organized granuloma
with macrophages, immature epithelioid cells,
lymphocytes, plasma cells and coarse predominantly
basophilic caseation necrosis (12%) and a non-reactive
type  unorganized granuloma with macrophages,
lymphocytes, plasma cells and polymorphs with non
caseating necrosis (5%).
Theimportanceofnakedeyeexaminationofnodes
should not be underestimated in the diagnosis, pending
confirmation by histology. In a Zambian study, 148 (79%)
of 188 cases of tuberculous lymphadenitis showed non-
caseating tuberculomata or caseation visible on naked eye
examination of the biopsied lymphnode 15. Someworkers
have described the usefulness of impression smears from
the cut surface of the lymphnode.
Fine Needle Aspiration Cytology
Recentlytherehavebeenanumberofreportsonthevalue
of Fine Needle Aspiration Cytology (FNAC), in the
diagnosis of tuberculous lymphadenitis with claims of
sensitivity and specificity of 80-90% and diagnostic
accuracy above 80%. This outpatient procedure has
provided an alternative and easymethod for collection of
material for cytomorphologic and bacteriologic
examination. Diagnosis of tuberculosis can be made by
the demonstration of epithelioid granulomas with or
without ceseation even in the absence of acid fast bacilli
(AFB).Necroticfeatureswhetheracellularoraccompanied
by neutrophilic infilitrate are usually misdiagnosed as
suppurative abscesses. Such smears however, show AFB
positivity and thus the diagnosis of tuberculosis is still
possible even in the absence of epithelioid granulomas.
Therefore, it has been suggested that all smears of
suspected tuberculous lesions obtained by FNAC should
be subjected to Ziehl-Neelson (ZN) staining forAFB16.
A study from Bombay has shown another
interesting diagnostic feature. FNAC smears sometimes
reveal multiple pink, homogenous structures with
irregular shape and well defined margins called
eosinophilic structures.Immuniperoxidase staining
demonstrated these eosinophilic structures to be
degenerated granuloma and thus form an extended
diagnostic criterion17.
FNAC is of particular use in patients presenting
with multiple nodes, a common enough clinical
presentation in our setting. In a patient with multiple
lymphadenopathy,decidingonwhichnodetobiopsycan
be difficult because some of the enlarged nodesmay not
reflect the truediseaseprocess.When sucha lymphnode
is biopsied, the actual diagnosis can be delayed or even
missed. FNAC is advantageous in such situations.Many,
if not all, of the enlarged lymph nodes can be sampled at
one sitting. If this procedure fails to provide a definitive
diagnosis, theclinicianshouldthenproceedtodoanopen
biopsy18.
However, the detection rate for Mycobacterium
tuberculosisfromtheaspiratedmaterial isusuallylowwith
ZN stain and even with culture. The application of the
polymerase chain reaction (PCR) formycobacterialDNA
to the aspirated material yields excellent results. PCR is
the most sensitive technique in the demonstration of
tuberculosis in patients with clinically suspected
tuberculosis of the lymph nodes, who haveAFB stain or
culture negative cytology 19.
FNAC can also be performed under ultrasound
guidance for deep seated nodes. It may be necessary to
preform several aspirations from different sites of the
enlarged lymphnode. ThusFNAC is a valuable addition
to the diagnostic armamentarium. A diagnosis of
granulomatous lymphadenitis consistent with
tuberculosis can be given even if acid-fast stains are
negative.Anopenbiopsyshouldberecommendedifthere
is a discrepancy with the clinical impression.
Bacteriology
Lymphnode tuberculosis, like other forms of extra-
pulmonary disease is a pauci bacillary condition.
Therefore, it is not surprising that in many studies on
lymphnodetuberculosis,theyieldofpositiveculturesfrom
the lymphnodes have not been high. However, using
appropriate techniques, it is possible to culture
Mycobacterium tuberculosis in a majority of the cases. At
the TRC, multiple media like LJ medium, LJ with
pyruvate,7OH11oleicacidmediumandliquidKirchners
mediumareused for culturingMycobacteriumtuberculosis
from extra pulmonary specimens including lymph-
nodes20. Using a transport medium (liquid Kirchners
medium) when there is a likely delay in sendingthe
specimen to the laboratory also contributes greatly to
increased culture positivity21.With thesemultiple culture
media, the culture positivity for lymphnode specimens
was 62% in the TRC Chennai study12 and 74% in the
Madurai study. These are high figures for extra-
pulmonary specimens andwaspossible onlywith theuse
ofmultiple culturemedia.Discharges fromsinuses should
also be cultured for mycobacteria. However, the use of
multipleculturemedia is feasibleonly inaresearchsetting.
Inwesterncountriesmycobacterial lymphadenitis
in children, except in the Asian immigrant community, is
caused almost exclusively by non-tuberculous
mycobacteria22,23. In India the causative agent is invariably
M.tuberculosis. Histologically, it is difficult to distinguish
lymphadenitis caused byM.tuberculosis from that caused
by non-tuberculous mycobacteria, though some authors
have described certain minor differentiating features24.
Tuberculin Test
The cutaneous reaction to PPD is often used as an aid to
the clinical diagnosis of tuberculous lymphadenitis in
practice. Pamra and Mathur found that in 22 children
below 15 years, with confirmed tuberculous
lymphadenitis, only one had an induration below 5mm,
whereas of 20 children in the same age group with
lymphadenitis of other causes, 11 had a reactionof less
than 5mm. If an induration of 10mmormore is taken as
evidence of postivity,then five of the 22 children would
be labeled as negative. The authors, therefore, suggested
that an induration 5mm to 1 TU PPD RT 23 should be
considered as evidence of infection9. In the TRCChennai
clinical trial, 154 of 168 (92%) children had an induration
of 10mm or more to 1 TU PPD RT 23. Only 14 (8%)
children had a negative reaction. What was interesting
was the large number of patientswith large reactions: one
hundredandfortyseven(88%)childrenhadaninduration
of 15 mm or more and 107 (64%) had induration of 20
mmormore12 . This tendency for large reactionswas also
observed in the TRCMadurai study.
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Radiology
Seventy one percent of the children with tuberculous
lymphadenitis in the TRC Chennai clinical trial had
normal chest X-rays12.
With the recent rapid advances in the science of
imagingtechnology, thesetechniqueshavealsobeenused
insuperficial lymphadenitis.Studieshavebeenpublished
on the value of Computed Tomography (CT) and
Magnetic Resonance Imaging (MRI) in lympha-denitis of
various causes25.While these sophisticated and expensive
techniques have a definite role in the diagnosis of intra
thoracic lymphadenopathy, their necessity in superficial
lymphadenitis is questionable.The diagnostic features on
CT scan of tuberculous lymphadenitis are central low
density and peripheral rim enhancement that tends to
be thick and irregular compared with a malignant
lymphadenopathy26.
MANAGEMENT
While the treatment of pulmonary tuberculosis has been
systematically studies over the years by a number of
randomizedclinicaltrialsinIndiaandelsewhere,thesame
is not true for lymphnode tuberculosis. There has never
been any consensus on themanagement of this disorder.
Practices adopted in the past have included complete
surgical excision of the node masses, anti  TB
chemotherapy of various duration and a combination of
the two27.
TheBritishThoracicSocietyResearchCommittee
first attempted to systematically study the medical
treatmentoftuberculouslymphadenitis.Inaseriesofthree
well designed prospective randomized clinical trials
between 1977 and 1993 the duration of treatment for this
disorderwas reduced progressively from 18months to 9
months to 6 months11,28,29,30. However, these studies were
in adult patients. There is paucity of information on the
treatment for tuberculous lymphadenitis in children. The
TRC, Chennai carried out the first collaborative clinical
trial on the efficacy of short course chemotherapy for
childhood tuberculous lymphadenitis12. In this study 168
children 1- 12 years of age with biopsy confirmed
tuberculous superficial lymphadenitis, were treatedwith
a fully supervised six month regimen consisting of
isoniazid, streptomycin, rifampicin and pyrazinamide
thrice a week for twomonths followed by isoniazid and
streptomycin twice a week for four months (2SHRZ3/
4SH2). The study inwhich patients were followed up for
fiveyears showed that the regimenwashighly successful
with a 95% cure rate. The response to treatment in the
children, a majority of whom had extensive and severe
lymphadenitiswasvery rapid. Inpatientspresentingwith
sinuses and abscesses, 81% of the lesions had healed by
one month of treatment, 95% by three months and all by
the endof treatment. The regimenwaswell toleratedwith
few patients experiencing side effects.
Meanwhile, evidence emerged that extrapulmo-
nary tuberculosis, being a paucibacillary condition could
be effectivelymanagedwith a lesspotent regimen. So the
TRC initiated the second clinical trial in Madurai, South
India, in which two six month regimens using only
rifampicin and isoniazid, with or without pyrazinamide
were compared for the treatment of tuerculous lympha-
denitis. The results will be published shortly.
A number of clinical trials have now shown the
efficacy of a six month short course regimen for the
treatment for superficial tuebrculous lymphadenitis. It is
now well established that surgery has a limited role in
the management of this disease. In review of the
management of 85 children with tuberculous
lymphadenitis,surgeryconsistedonlyofproceduressuch
as a diagnostic biopsy or rebiopsy, FNAC, drainage of
abscesses and excision of sinuses 31. AT TRC there was
neveranoccasiontoresort toexcisionofnodesatanystage
in the two clinical trials.
A matter of practical importance in the manage-
ment of tuberculous lymphadenitis is the occurrence of
enlargementof nodesor theappearanceofnewnodesafter
treatment is initiated. Fresh abscesses sometimes appear
or existing abscesses break down. These events usually
subside spontaneously when treatment is continued
without modification or change of the regimen. These
events are also observed after treatment is completed and
whenpatientsarefollowedup.IntheTRCChennaiclinical
trial 32 patients had 36 episodes of enlargement or fresh
appearance of nodes and fresh abscesses and sinuses
appeared in four and six patients respectively12. These
paradoxical responses have been reported by many
authors and probably represent an immune response to
the release of mycobacterial products caused by the
bactericidal activity of the regimens 11,28,29,30. This
observation is of great practical importance as the
appearance of new nodes or the enlargement of nodes
while on treatment is often a cause of alarm to thepatient
and of concern to the treating physician. However, this
development is not always an indication that treatment
has failed and often does not warrant a change of the
treatment regimen.
It is also important to realize that thenodesdonot
always disappear completely at the end of treatment.
Thirty percent of patients in the TRC Chennai study had
residual small nodes palpable (<10mm diameter) at the
end of successful chemotherapy 12. Repeat biopsy showed
that inmostof thesecases thehistologywasnotsuggestive
of tuberculosis and the culture for mycobacteria was
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negative.
The Revised National Tuberculosis Control
Programme (RNTCP), being implemented in a phased
manner all over the country categorizes tuberculosis
patientsintothreegroupsforpurposesoftreatment,based
on site and severity of disease, and whether the patient
had received any treatment for tuberculosis in the past33.
Extra pulmonary tuebrculosis, other than severe forms
(such as meningitis, gastro-intestinal, renal, pericardia,
spinal and disseminated TB) is classified as category III
and the regimen recommended is two months of
rifampicin, isoniazid,andpyrazinamide followedbyfour
months of rifampicin and isoniazid, three times a week
throughout (2RHZ3/4RH3). Numerous clinical trials in
India and elsewhere have proved the efficacy of
intermittent treatment for tuberculosis. Intermittent
regimens,wherethedrugsareadministeredtwiceorthrice
aweekrather thandaily, areaseffectiveasdaily regimens
while proving less expensive and less toxic. They also
permitthedirectsupervisionoftreatment,thecornerstone
of the DOTS strategy of the RNTCP. Thus, lymphnode
tuberculosiswithoutpulmonary involvement in children
can be successfully treated with this regimen.
Thedosagerecommendedisasfollows:thethrice
weekly dosage is used in the RNTCP.
Daily(mgm/kg) Thriceweekly(mgm/kg)
Isoniazid 5 10
Rifampicin 10 10
Pyrazinamide 25 35
Streptomycin 15 15
SUMMARY
1. Superficial lymphnode tuberculosis is the
commonest form of extra pulmonarytuberculosis
constituting about 7 - 10% of all cases. It is
predominantly a disease of children and young
adults in our country.
2. Cervical nodes are most commonly affected.
Multiplenodeinvolvementiscommon,particularly
in children.
3. The causative agent is almost alwaysMycobacterium
tuberculosis in India.
4. Clinical diagnosis, especially in children has poor
specificity. Biopsy should be done whenever
possible. FNAC should be used as a screening
procedure.
5. Treatment with short course chemotherapy is very
effective.Theregimenrecommended is twomonths
of rifampicin, isoniazid andpyrazinamide followed
by four months of rifampicin and isoniazid, three
times a week thoughout.
6. Theroleof surgery isusually reservedfordiagnostic
biopsy and draining of abscesses, if necessary.
7. Lymphnodesmayenlargeornewnodesmayappear
during treatment. In most instances this does not
warrant a change of treatment.
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